Mechanism of Bispecific Antibodies and Clinical Research Advances in Lung Cancer.
- DOI
- 10.2174/0115680096353819250127065001
- Published
- 2026-01-01
- Container
- Curr Cancer Drug Targets
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2174/0115680096353819250127065001,
title = {Mechanism of Bispecific Antibodies and Clinical Research Advances in Lung Cancer.},
author = {Yang J and Liang Y and Zhu M and Meng Y and Wang X and Yu M and Li L and Kong F.},
year = {2026},
journal = {Curr Cancer Drug Targets},
doi = {10.2174/0115680096353819250127065001},
url = {https://doi.org/10.2174/0115680096353819250127065001}
}RIS
TY - JOUR TI - Mechanism of Bispecific Antibodies and Clinical Research Advances in Lung Cancer. AU - Yang J AU - Liang Y AU - Zhu M AU - Meng Y AU - Wang X AU - Yu M AU - Li L AU - Kong F. PY - 2026 JO - Curr Cancer Drug Targets DO - 10.2174/0115680096353819250127065001 UR - https://doi.org/10.2174/0115680096353819250127065001 ER -
APA
J, Y., Y, L., M, Z., Y, M., X, W., M, Y., L, L., & F., K. (2026). Mechanism of Bispecific Antibodies and Clinical Research Advances in Lung Cancer.. Curr Cancer Drug Targets. https://doi.org/10.2174/0115680096353819250127065001
Source records
- europe-pmc · retrieved 2026-09-27T02:22:14.565Z